CD8A and myeloid sarcoma: From an autoimmunity standpoint, activating mutations in CD8 + T cells are interesting because of these cells' role as autoimmune effectors in a mouse model [28], their high abundance in active MS lesions [29], and significant genetic effects of CD8 + cell's antigen recognition molecules, HLA class I in MS [30].